Getting in early with companies like Tesla ($149.93|-3.55%) or Shopify ($69.51|0.14%) have provided some investors with life-changing gains. Of course, the most difficult part is finding a company that has this potential in the first place.
What should we be looking for? The usual factors that make any company successful: strong leadership and disrupting an existing industry, or better, creating a new one. You only need a few of these to change your life forever, so don’t be surprised if some of your investments don’t pan out the way you thought. Nobody bats at 100%, and even the most experienced investors miss the boat. Let’s take a look at two stocks that are newer to the market, that could grow by 1,000% or more in the future!
ASTS Spacemobile (NASDAQ:ASTS): This SPAC merger flew under the radar for most, but there was a time when this stock hit a high of $25.00 per share before it merged with ASTS. But what does the company do? It’s going to sound like something out of a science fiction movie, but ASTS is planning to send satellites into space that will provide the world with a blanket of broadband and mobile technology. Think Elon Musk’s Starlink, but for mobile phone coverage. Okay, this may sound like a crazy idea, but imagine if ASTS is able to pull this off. The company quite literally has a total addressable market of 5 billion smartphone users, a number that is only going to grow with time. It also has some high-end investors including Rakuten, NEC, AT&T, Vodafone, Samsung, and American Tower. The company is targeting developing regions of the world like Africa and India, who have a high population density but low access to reliable mobile connections. This is extremely speculative, so a small position is all you may need. ASTS is the first mover in an industry they basically created themselves. If it hits anywhere close to what it is projecting, its current share price of just over $12.00 will seem like a bargain ten years from now.
ClearPoint Neuro Inc (NASDAQ:CLPT): If you spend any time on FinTwit, you have no doubt heard about ClearPoint Neuro. Now brain surgery probably is not everyone’s wheelhouse, it’s certainly not in mine. But for decades the only technology that has been available to take scans of our brains has been giant, expensive machines like MRIs. ClearPoint is trying to change that. Enter the ClearPoint Neuro Navigation System, which will utilize robotics and software to give neurologists a clear scan of the brain. That seems cool, but will it be adopted? Yes! ClearPoint’s systems are already in use across 60 centers in North America and Europe, with anticipated growth to over 100 by 2025. But what about the competition? ClearPoint is actually already working alongside companies like Siemens, General Electric, Phillips, Medtronic, and Boston Scientific. And it’s not just hardware! ClearPoint has a razor and blade model that will charge users for services and disposable components, with an estimated 85% of its revenue from this recurring form of fees. ClearPoint is also involved as a platform for gene therapy, a market that the company says will be $1.5 billion by 2025. It is already heavily involved in finding and developing treatments for epilepsy, depression, parkinson’s, alzeheimer’s, and stroke therapy. I’m not saying it is the same company, but ClearPoint Neuro in 2021 gives off the same impression that Intuitive Surgical (NASDAQ:ISRG) did ten years ago.
Rate this article